The A&D Board
The A&D Board is responsible for the decision-making on Accreditation and Designation procedures and policies. Furthermore, the A&D Board decides on the important steps in the programme, e.g. application approval, preliminary designation, decision go / no go peer review, certification and designation.
Jean Benoit Burrion
Chair of the A&D Board
Head of Preventive and Screening Clinic
Institut Jules Bordet
Brussels, Belgium
Mef Nilbert
Vice-Chair of the A&D Board
Professor of Oncology, Senior Consultant Institute of Clinical Sciences, Division of Oncology
Lund University, Skane University Hospital Cancer Center
Lund, Sweden
Wim van Harten
Board Director
Rijnstate Ziekenhuis
Arnhem, The Netherlands
Vanesa Gregorc
Deputy Scientific Director
Candiolo Cancer Institute FPO-IRCCS
Candiolo, Italy
John V. Reynolds
Professor & Head of Department, Surgery
Trinity College Dublin
Dublin, Ireland
Eva Jolly-Gustafsson
Head of Patient Care Unit Radiotherapy, Theme Cancer
Karolinska University Hospital
Stockholm, Sweden
Paulina Bravo
Director of Patient Education and Involvement | Patient Expert
Fundación Arturo López Pérez
Providencia, Chile
Peter Nagy
Scientific Director
National Institute of Oncology
Budapest, Hungary
Claire Noonan
Cancer Accreditation Lead
Beaumont RCSI Cancer Centre
Dublin, Ireland
Jorrit Enserink
Professor and Research Group Leader
Oslo University Hospital CCC
Oslo, Norway
Simon Oberst
Director of Quality and Accreditation
Invited Member to the A&D Board
Brussels, Belgium
Claudio Lombardo
OECI General Manager
Invited Member to the A&D Board
Brussels, Belgium - Genoa, Italy
József Lövey
Chair of the OECI Accreditation Committee
Oslo University Hospital CCC
Oslo, Norway